×
About 17,016 results

ALLMedicine™ Gout Center

Research & Reviews  6,825 results

The incidence and prevalence of cardiovascular diseases in gout: a systematic review an...
https://doi.org/10.1007/s00296-021-04876-6 10.1136/annrheumdis-2013-204463 10.1093/rheumatology/kez196 10.1093/rheumatology/kes169 10.1097/BOR.0b013e3283438e13 10.7326/0003-4819-143-7-200510040-00009 10.1002/art.24612 10.1016/0895-4356(88)90127-8 10.1001/archinte.1997.00440340060005 10.1093/rheumatology/ket293 10.1186/s13075-020-02175-2 10.1371/journal.pmed.1000097 10.1136/rmdopen-2018-000712 10.1007/s10067-006-0292-4 10.1097/RHU.0000000000000496 10.1016/j.jbspin.2015.12.003 10.1186/s13075-018-1606-z 10.1136/annrheumdis-2014-205252 10.1186/s13075-015-0842-8 10.1038/s41598-016-0001-8 10.1016/j.thromres.2016.06.020 10.1016/S1098-3015(10)75141-X 10.1093/rheumatology/kez398 10.1503/cmaj.180717 10.1097/MD.0000000000002140 10.1007/s10067-019-04520-6 10.1093/rheumatology/kep364 10.1093/qjmed/hct083 10.1093/rheumatology/kes194 10.1371/journal.pone.0141749 10.1136/annrheumdis-2015-208161 10.1016/j.amjmed.2016.09.005 10.1093/fampra/cmg413 10.1016/j.amjmed.2011.09.033 10.1093/rheumatology/keaa246 10.1161/CIRCULATIONAHA.107.703389 10.1136/heartjnl-2019-316193 10.1136/annrheumdis-2012-201669 10.3899/jrheum.160185 10.1016/s0140-6736(16)00346-9 10.1186/1471-2261-12-108 10.1093/rheumatology/kep069 10.1016/j.amjmed.2015.11.003 10.2215/CJN.01580210 10.1371/journal.pone.0099102 10.1097/HJH.0b013e3282f240bf 10.1161/hy1101.092839 10.1136/annrheumdis-2016-210357 10.1161/01.STR.0000221716.55088.d4 10.1631/jzus.2007.B0593 10.1038/s41598-019-56847-4 10.1016/j.trsl.2017.01.001
Rheumatology International; Cox P, Gupta S et. al.

May 14th, 2021 - The aims of this systematic review and meta-analysis were to describe prevalence of cardiovascular disease in gout, compare these results with non-gout controls and consider whether there were differences according to geography. PubMed, Scopus and...

Assessing the Causal Relationships between Insulin Resistance and Hyperuricemia and Gou...
https://doi.org/10.1002/art.41779
Arthritis & Rheumatology (Hoboken, N.J.); McCormick N, O'Connor MJ et. al.

May 13th, 2021 - Hyperuricemia is closely associated with insulin resistance syndrome (and its many cardiometabolic sequalae); however, whether they are causally related has long been debated. We used bidirectional Mendelian randomization (MR) to investigate the p...

Efficacy of Ayurvedic treatment protocol in gouty arthritis - a clinical study.
https://doi.org/10.1515/jcim-2020-0301
Journal of Complementary & Integrative Medicine; Vaprath Kuniyil AR, Soman D et. al.

May 12th, 2021 - Gout is an inflammatory response to the Monosodium urate crystals formed secondary to hyperuricaemia. The prevalence of gout has increased in recent years. The current conventional medical management aims at symptomatic management. In Ayurveda, go...

Coronavirus disease 2019 (COVID-19)-associated constrictive pericarditis.
https://doi.org/10.1136/bcr-2021-242018
BMJ Case Reports; Beckerman JK, Alarfaj M et. al.

May 12th, 2021 - This report documents a rare case of COVID-19-associated constrictive pericarditis (CP) in the setting of a recent COVID-19 infection. A 55-year-old man with a history of hypertension and gout presented with acute hypoxic respiratory failure and w...

Colchicine and the heart.
https://doi.org/10.1093/eurheartj/ehab221
European Heart Journal; Imazio M, Nidorf M

May 7th, 2021 - Colchicine is a unique, sophisticated anti-inflammatory agent that has been used for decades for the prevention of acute inflammatory flares in gout and familial Mediterranean fever. In recent years, clinical trials have demonstrated its potential...

see more →

Guidelines  47 results

Comparative Performances of Sodium-Glucose Cotransporter-2 Inhibitors in Reducing Gout in Type 2 Diabetes
https://www.rheumatologyadvisor.com/home/conference-highlights/acr-convergence-2020/comparative-performance-of-sglt2-inhibitors-in-reducing-gout-in-t2d/

Nov 8th, 2020 - Among patients with type 2 diabetes (T2D), sodium-glucose cotransporter-2 (SGLT2) inhibitors dapagliflozin and empagliflozin vs canagliflozin show greater benefit in reducing gout, according to research results presented at the American College of...

Managing Gout
https://www.jwatch.org/na51787/2020/06/11/managing-gout
NEJM Journal Watch;

Jun 10th, 2020 - The ACR has updated its 2012 guideline on managing gout. Each recommendation is rated as “strong” (supported by moderate- or high-certainty evidence) or “conditional” (benefits and risks are closely balanced, or only low-certainty evidence or no d...

2020 American College of Rheumatology Guideline for the Management of Gout.
https://doi.org/10.1002/art.41247
Arthritis & Rheumatology (Hoboken, N.J.); FitzGerald JD, Dalbeth N et. al.

May 11th, 2020 - To provide guidance for the management of gout, including indications for and optimal use of urate-lowering therapy (ULT), treatment of gout flares, and lifestyle and other medication recommendations. Fifty-seven population, intervention, comparat...

Rising Incidence of Acute Hospital Admissions due to Gout
http://www.jrheum.org/content/47/4/619.long
The Journal of Rheumatology; Russell MD

Mar 31st, 2020 - To describe trends in acute hospital admissions due to gout in England, with rheumatoid arthritis (RA) as a comparator, alongside prescribing trends for common gout medications.

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
https://www.nejm.org/doi/full/10.1056/NEJMoa1912388?query=featured_home
New England Journal of Medicine; Tardif JC et al

Nov 16th, 2019 - Experimental and clinical evidence support the role of inflammation in atherosclerosis and its complications. Colchicine is an orally administered, potent antiinflammatory medication that is indicated for the treatment of gout and pericarditis.

see more →

Drugs  613 results see all →

Clinicaltrials.gov  8,257 results

The incidence and prevalence of cardiovascular diseases in gout: a systematic review an...
https://doi.org/10.1007/s00296-021-04876-6 10.1136/annrheumdis-2013-204463 10.1093/rheumatology/kez196 10.1093/rheumatology/kes169 10.1097/BOR.0b013e3283438e13 10.7326/0003-4819-143-7-200510040-00009 10.1002/art.24612 10.1016/0895-4356(88)90127-8 10.1001/archinte.1997.00440340060005 10.1093/rheumatology/ket293 10.1186/s13075-020-02175-2 10.1371/journal.pmed.1000097 10.1136/rmdopen-2018-000712 10.1007/s10067-006-0292-4 10.1097/RHU.0000000000000496 10.1016/j.jbspin.2015.12.003 10.1186/s13075-018-1606-z 10.1136/annrheumdis-2014-205252 10.1186/s13075-015-0842-8 10.1038/s41598-016-0001-8 10.1016/j.thromres.2016.06.020 10.1016/S1098-3015(10)75141-X 10.1093/rheumatology/kez398 10.1503/cmaj.180717 10.1097/MD.0000000000002140 10.1007/s10067-019-04520-6 10.1093/rheumatology/kep364 10.1093/qjmed/hct083 10.1093/rheumatology/kes194 10.1371/journal.pone.0141749 10.1136/annrheumdis-2015-208161 10.1016/j.amjmed.2016.09.005 10.1093/fampra/cmg413 10.1016/j.amjmed.2011.09.033 10.1093/rheumatology/keaa246 10.1161/CIRCULATIONAHA.107.703389 10.1136/heartjnl-2019-316193 10.1136/annrheumdis-2012-201669 10.3899/jrheum.160185 10.1016/s0140-6736(16)00346-9 10.1186/1471-2261-12-108 10.1093/rheumatology/kep069 10.1016/j.amjmed.2015.11.003 10.2215/CJN.01580210 10.1371/journal.pone.0099102 10.1097/HJH.0b013e3282f240bf 10.1161/hy1101.092839 10.1136/annrheumdis-2016-210357 10.1161/01.STR.0000221716.55088.d4 10.1631/jzus.2007.B0593 10.1038/s41598-019-56847-4 10.1016/j.trsl.2017.01.001
Rheumatology International; Cox P, Gupta S et. al.

May 14th, 2021 - The aims of this systematic review and meta-analysis were to describe prevalence of cardiovascular disease in gout, compare these results with non-gout controls and consider whether there were differences according to geography. PubMed, Scopus and...

Assessing the Causal Relationships between Insulin Resistance and Hyperuricemia and Gou...
https://doi.org/10.1002/art.41779
Arthritis & Rheumatology (Hoboken, N.J.); McCormick N, O'Connor MJ et. al.

May 13th, 2021 - Hyperuricemia is closely associated with insulin resistance syndrome (and its many cardiometabolic sequalae); however, whether they are causally related has long been debated. We used bidirectional Mendelian randomization (MR) to investigate the p...

Efficacy of Ayurvedic treatment protocol in gouty arthritis - a clinical study.
https://doi.org/10.1515/jcim-2020-0301
Journal of Complementary & Integrative Medicine; Vaprath Kuniyil AR, Soman D et. al.

May 12th, 2021 - Gout is an inflammatory response to the Monosodium urate crystals formed secondary to hyperuricaemia. The prevalence of gout has increased in recent years. The current conventional medical management aims at symptomatic management. In Ayurveda, go...

Coronavirus disease 2019 (COVID-19)-associated constrictive pericarditis.
https://doi.org/10.1136/bcr-2021-242018
BMJ Case Reports; Beckerman JK, Alarfaj M et. al.

May 12th, 2021 - This report documents a rare case of COVID-19-associated constrictive pericarditis (CP) in the setting of a recent COVID-19 infection. A 55-year-old man with a history of hypertension and gout presented with acute hypoxic respiratory failure and w...

Colchicine and the heart.
https://doi.org/10.1093/eurheartj/ehab221
European Heart Journal; Imazio M, Nidorf M

May 7th, 2021 - Colchicine is a unique, sophisticated anti-inflammatory agent that has been used for decades for the prevention of acute inflammatory flares in gout and familial Mediterranean fever. In recent years, clinical trials have demonstrated its potential...

see more →

News  1,225 results

Point-Counterpoint: The Future of Rheumatology Is Sub-Subspecialization
https://www.medscape.com/viewarticle/947550

Mar 15th, 2021 - Sub-Subspecialization Would Be Counterproductive: Orrin M. Troum, MD The much-discussed looming rheumatology workforce shortage is actually here already. And it's going to worsen rapidly. Add to that the striking geographic maldistribution of rheu...

Second UK Trial to Study Gout Drug Colchicine as COVID-19 Treatment
https://www.medscape.com/viewarticle/946763

Mar 3rd, 2021 - Gout medication colchicine will be tested in a large UK study looking into potential early-stage COVID-19 treatments and enrollment criteria was widened for the latest arm of the trial, University of Oxford researchers said on Wednesday. The drug ...

New Gout Guidelines: Primary Care Pointers
https://www.medscape.com/viewarticle/945951

Mar 1st, 2021 - This transcript has been edited for clarity. I'm Dr Neil Skolnik. Today we are going to talk about the 2020 American College of Rheumatology Guideline for the Management of Gout and get some really clear evidence-based guidance about treating gout...

Association Between Gout and Comorbidities is Independent of Serum Urate Level
https://www.medscape.com/viewarticle/943485

Jan 3rd, 2021 - Takeaway Cardiovascular comorbidities and chronic kidney disease (CKD) associate with increasing serum urate (SU) in modest (e.g. 1 mg/dl) increments.

Weight Loss May Be Paramount Lifestyle Change in Preventing Gout
https://www.medscape.com/viewarticle/943128

Dec 22nd, 2020 - A recent analysis of the incidence of gout in men, published in JAMA Network Open, offers new insights on the role of lifestyle changes in preventing gout, particularly the importance of obesity and its modification. Prior gout research, although ...

see more →

Patient Education  49 results see all →